About this Journal Submit a Manuscript Table of Contents
International Journal of Rheumatology
Volume 2009 (2009), Article ID 268569, 10 pages
http://dx.doi.org/10.1155/2009/268569
Research Article

Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database

1Monash Department of Clinical Epidemiology, Cabrini Institute, 183 Wattletree Road, Malvern, VIC 3144, Australia
2Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, VIC 3004, Australia
3Austin Spondylitis Clinic, Austin Health, Studley Road, Heidelberg, VIC 3084, Australia
4Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, VIC 3800, Australia
5School of Physiotherapy, Curtin University of Technology, WA 6000, Australia
6Department of Rheumatology, St George Hospital, NSW 2217, Australia
7Department of Rheumatology, Royal North Shore Hospital, NSW 2065, Australia
8Institute of Bone and Joint Research, University of Sydney, NSW 2065, Australia

Received 13 April 2009; Accepted 28 May 2009

Academic Editor: Malcolm D. Smith

Copyright © 2009 John Oldroyd et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

John Oldroyd, Lionel Schachna, Rachelle Buchbinder, et al., “Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database,” International Journal of Rheumatology, vol. 2009, Article ID 268569, 10 pages, 2009. doi:10.1155/2009/268569